Lipocine Inc.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 7, 2026 8-K
4 Oct 1, 2026 4
4 Sep 30, 2026 4
8-K Sep 16, 2026 8-K
8-K Sep 14, 2026 8-K
8-K Sep 11, 2026 8-K
8-K Sep 10, 2026 8-K
8-K/A Aug 21, 2026 8-K/A
SCHEDULE 13G/A Aug 14, 2026
4 Aug 7, 2026 4
3 Aug 7, 2026 3
8-K Aug 4, 2026 8-K
10-Q Aug 4, 2026 10-Q
8-K Aug 3, 2026 8-K
4 Jun 30, 2026 4
8-K Jun 12, 2026 8-K
S-8 Jun 9, 2026 S-8
8-K Jun 4, 2026 8-K
4 Jun 4, 2026 4
4 Jun 4, 2026 4
4 Jun 4, 2026
8-K Jun 4, 2026 8-K
8-K May 26, 2026 8-K
8-K May 19, 2026 8-K
8-K May 18, 2026 8-K
← Newer Page 1 of 33 · 820 filings Older →